Recent advances in pathogenic concepts and therapeutic strategies in Rasmussen's encephalitis;Avancées actuelles sur les concepts pathogéniques et thérapeutiques de l'encéphalite de Rasmussen

Revue Neurologique

Volumn 161, Issue 4, 2005, Pages 395-405

  Bahi Buisson, N ^a   Nabbout, R ^a   Plouin, P ^a   Bulteau, C ^b   Delalande, O ^b   Hertz Pannier, L ^a   Dulac, O ^a   Chiron, C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

Author keywords

Epilepsia partialis continua; Epileptic encephalopathy; Rasmussen

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; ZIDOVUDINE;

CLINICAL FEATURE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; ELECTROENCEPHALOGRAM; HEMISPHERECTOMY; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PLASMAPHERESIS; RASMUSSEN SYNDROME; REVIEW; SYSTEMATIC REVIEW;

EID: 17644370603     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(05)85069-6     Document Type: Review

References (65)

1. ANDREWS PI, DICHTER MA, BERKOVIC SF, NEWTON MR, MCNAMARA JO. (1996). Plasmapheresis in Rasmussen's encephalitis. Neurology, 46: 242-246.
2. ANDREWS PI, MCNAMARA JO, LEWIS DV. (1997). Clinical and electroencephalographic correlates in Rasmussen's encephalitis. Epilepsia, 38:189-194.
3. ANTOZZI C, GRANATA T, AURISANO N et al. (1998). Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology, 51: 302-305.
4. ASHER D, GAJDUSEK D. (1991). Virologic studies in chronic encephalitis. In: F Andermann (eds). Chronic encephalitis and epilepsy. Rasmussen's syndrome, pp. 147-158. Butterworth-Heinemann. Boston.
5. ATKINS MR, TERRELL W, HULETTE CM. (1995). Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol, 14: 7-12.
6. AUBOURG P, DULAC O, PLOUIN P, DIEBLER C. (1985). Infantile status epilepticus as a complication of "near-miss" sudden infant death. Dev Med Child Neurol, 27: 40-48.
7. BANATI RB, GOERRES GW, MYERS R et al. (1999). [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology, 53: 2199-2203.
8. BIEN CG, BAUER J, DECKWERTH TL et al. (2002a). Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol, 51: 311-318.
9. BIEN CG, GLEISSNER U, SASSEN R, WIDMAN G, URBACH H, ELGER CE. (2004). An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology, 62: 2106-2109.
10. BIEN CG, URBACH H, DECKERT M et al. (2002b). Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology, 58: 250-257.
11. BIEN CG, WIDMAN G, URBACH H et al. (2002c). The natural history of Rasmussen's encephalitis. Brain, 125: 1751-1759.
12. CHINCHILLA D, DULAC O, ROBAIN O et al. (1994). Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry, 57: 1325-1333.
13. CONFORD E AND OLDENFORD W. (1986). Epilepsy and blood-brain barrier. In: A Delgado-Escueta, Ward, A, Woodbury, D, Porter, R (eds). Advances in Neurology: basic mechanisms of epilepsies, pp 787-812. Raven Press. New York.
14. COOK SW, NGUYEN ST, Hu B et al. (2004). Cerebral hemispherectomy in pediatric patients with epilepsy: comparison of three techniques by pathological substrate in 115 patients. J Neurosurg Spine, 100: 125-141.
15. DANIEL RT, VILLEMURE JG. (2003). Hemispherotomy techniques. J Neurosurg, 98: 438-439; author reply 439.
16. DELALANDE O, PINARD J, BASDEVANT C. (1992). Hemispherotomy: a new procedure for central disconnection. Epilepsia, 33 (Supp 13): 99-100.
17. DETOLEDO JC, SMITH DB. (1994). Partially successful treatment of Rasmussen's encephalitis with zidovudine: symptomatic improvement followed by involvement of the contralateral hemisphere. Epilepsia, 35: 352-355.
18. DUCHOWNY M. (2004). Hemispherectomy for epilepsy: When is one half better than two? Neurology, 62: 1664-1665.
19. DULAC O, ROBAIN O, CHIRON C, PLOUIN P. (1991). High-dose steroid treatment of epilepsia partialis continua due to chronic focal encephalitis. In: F Andermann (eds). Chronic encephalitis and epilepsy. Rasmussen's syndrome, Butterworth-Heinemann. Boston.
20. FRIEDMAN H, CH'IEN L, PARHAM D. (1977). Virus in brain of child with hemiplegia, hemiconvulsions, and epilepsy. Lancet, 2: 666.
21. GAHRING L, CARLSON NG, MEYER EL, ROGERS SW. (2001). Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J Immunol, 166: 1433-1438.
22. GRANATA T. (2003). Rasmussen's syndrome. Neurol Sci, 24 (Suppl) 4: S239-243.
23. GRANATA T, GOBBI G, SPREAFICO R et al. (2003a). Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology, 60: 422-425.
24. GRANATA T, Fusco L, GOBBI G et al. (2003b). Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology, 61: 1807-1810.
25. HART Y, ANDERMANN F. (2000). Rasmussen syndrome. In: PC Oxbury JM, Duchowny M (eds). Intractable focal epilepsy, pp. 233-248. W.B. Saunders. London.
26. HART YM, CORTEZ M, ANDERMANN F et al. (1994). Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology, 44: 1030-1036.
27. HE XP, PATEL M, WHITNEY KD, JANUMPALLI S, TENNER A, MCNAMARA JO. (1998). Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron, 20: 153-163.
28. HERTZ-PANNIER L, CHIRON C, JAMBAQUE I et al. (2002). Late plasticity for language in a child's non-dominant hemisphere: a pre- and post-surgery fMRI study. Brain, 125: 361-372.
29. JAY V, BECKER LE, OTSUBO H et al. (1995). Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology, 45: 108-117.
30. JONAS R, NGUYEN S, Hu B et al. (2004). Cerebral hemispherectomy: Hospital course, seizure, developmental, language, and motor outcomes. Neurology, 62: 1712-1721.
31. KAZATCHKINE MD, KAVERI SV. (2001). Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med, 345: 747-755.
32. KOSSOFF EH, VINING EPG, PILLAS DJ et al. (2003). Hemispherectomy for intractable unihemispheric epilepsy Etiology vs outcome. Neurology, 61: 887-890.
33. KRAUSS GL, CAMPBELL ML, ROCHE KW, HUGANIR RL, NIEDERMEYER E. (1996). Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3. Neurology, 46: 247-249.
34. KRYNAUW RW. (1950). Infantile hemiplegia treated by removal of one cerebral hemisphere. S Afr Med J, 24: 539-546.
35. LEACH JP, CHADWICK DW, MILES JB, HART IK. (1999). Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology, 52: 738-742.
36. LEVITE M, FLEIDERVISH IA, SCHWARZ A, PELLED D, FUTERMAN AH. (1999). Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun, 13: 61-72.
37. MANTEGAZZA R, BERNASCONI P, BAGGI F et al. (2002). Antibodies against GluRS peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol, 131: 179-185.
38. McLACHLAN RS, LEVIN S, BLUME WT. (1996). Treatment of Rasmussen's syndrome with ganciclovir. Neurology, 47: 925-928.
39. OGUNI H, ANDERMANN F, RASMUSSEN TB. (1991). The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. In: F Andermann (eds). Chronic encephalitis and epilepsy. Rasmussen's syndrome, pp. Butterworth-Heinemann. Boston.
40. OGUNI H, ANDERMANN F, RASMUSSEN TB. (1992). The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases. Adv Neurol, 57: 419-433.
41. PALCOUX JB, CARLA H, TARDIEU M et al. (1997). Plasma exchange in Rasmussen's encephalitis. Ther Apher, 1: 79-82.
42. PANDIAN JD, THOMAS SV, SANTOSHKUMAR B et al. (2002). Epilepsia partialis continua - a clinical and electroencephalography study. Seizure, 11: 437-441.
43. PASTERNAK JF, DE Vivo DC, PRENSKY AL. (1980). Steroid-responsive encephalomyelitis in childhood. Neurology, 30: 481-486.
44. PIATT JH, HWANG PA, ARMSTRONG DC, BECKER LE, HOFFMAN HJ. (1988). Chronic focal encephalitis (Rasmussen syndrome): six cases. Epilepsia, 29: 268-279.
45. POSER CM, GOUTIERES F, CARPENTIER MA, AICARDI J. (1986). Schilder's myelinoclastic diffuse sclerosis. Pediatrics, 77: 107-112.
46. POWER C, POLAND SD, BLUME WT, GIRVIN JP, RICE GP. (1990). Cytomegalovirus and Rasmussen's encephalitis. Lancet, 336: 1282-1284.
47. RASMUSSEN T. (1978). Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol, 41: 1-12.
48. RASMUSSEN T. (1983). Hemispherectomy for seizures revisited. Can J Neurol Sci, 10: 71-78.
49. RASMUSSEN TB, OLSZEWSKI J, LLOYD-SMITH D. (1958). Focal Seizures due chronic localized encephalitis. Neurology, 8: 435-445.
50. ROBITAILLE Y. (1991). Neuropathologic aspects of chronic encephalitis. In: F Andermann (eds). Chronic encephalitis and epilepsy: Rasmussen's syndrome, pp. 89-110. Butterworth-Heinemann. Boston.
51. ROGER J, DRAVET C, BUREAU M. (1982). Unilateral seizures: hemi-convulsions-hemiplegia syndrome (HH) and nemiconvulsions-hemiplegia- epilepsy syndrome (HHE). Electroencephalogr Clin Neurophysiol Suppl: 211-221.
52. ROGERS SW, ANDREWS PI, GAHRING LC et al. (1994). Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science, 265: 648-651.
53. SCHRAMM J, BEHRENS E, ENTZIAN W. (1995). Hemispherical deafferentation: an alternative to functional hemispherectomy. Neurosurgery, 36: 509-515; discussion 515-506.
54. SHIMIZU H, MAEHARA T. (2000). Modification of peri-insular hemispherotomy and surgical results. Neurosurgery, 47: 367-372; discussion 372-363.
55. SOREL L, RUCQUOY-PONSAR M. (1972). [Spasm in flexion disease in early childhood with typical and atypical symptomatology and its treatment. Apropos of 192 cases], Int J Neurol, 9: 61-72.
56. THOMAS JE, REAGAN TJ, KLASS DW. (1977). Epilepsia partialis continua. A review of 32 cases. Arch Neurol, 34: 266-275.
57. TWYMAN RE, GAHRING LC, SPIESS J, ROGERS SW. (1995). Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron, 14: 755-762.
58. Van Empelen R, Jennekens-Schinkel A, Buskens E, Helders PJM, van Nieuwenhuizen O. (2004). Functional consequences of hemispherectomy. Brain: awh224.
59. VILLANI F, AVANZINI G. (2002). The use of immunoglobulins in the treatment of human epilepsy. Neurol Sci, 23 (Suppl 1): S33-37.
60. VILLEMURE JG, MASCOTT CR. (1995). Peri-insular hemispherotomy: surgical principles and anatomy. Neurosurgery, 37: 975-981.
61. WALSH JP. (1991). Treatment of Rasmussen's syndrome with intravenous gammaglobulin. In: F Andermann (eds). Chronic encephalitis and epilepsy. Rasmussen's syndrome, pp. Butterworth-Heinemann. Boston.
62. WALTER GF, RENELLA RR. (1989). Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet, 1: 279-280.
63. WIENDL H, BIEN CG, BERNASCONI P et al. (2001). GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology, 57: 1511-1514.
64. WISE MS, RUTLEDGE SL, KUZNIECKY RI. (1996). Rasmussen syndrome and long-term response to gamma globulin. Pediatr Neurol, 14: 149-152.
65. YAMATOGI Y, OHTSUKA Y, ISHIDA T et al. (1979). Treatment of the Lennox syndrome with ACTH; a clinical and electroence-phalographic study. Brain Dev, 1: 267-276.